ArticleGut2006
To be or not to be--an incretin or enterogastrone?
Article in Gut, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02308254 (Effects of Lixisenatide on Gastric Emptying, Glycaemia and 'Postprandial' Blood Pressure in Type 2 Diabetes and Healthy Subjects.), which is not on this map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Effects of Lixisenatide on Gastric Emptying, Glycaemia and 'Postprandial' Blood Pressure in Type 2 Diabetes and Healthy Subjects.
Who cites it
11 citing papers in PubMed.
- Exogenous glucose-dependent insulinotropic polypeptide worsens post prandial hyperglycemia in type 2 diabetes.Diabetes · 2009Trial
- The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study.Critical care (London, England) · 2009Trial
- Glucagon-like-peptide-1 receptor agonists and the management of type 2 diabetes-backwards and forwards.World journal of diabetes · 2024Article
- Central and Peripheral Fatigue Evaluation during Physical Exercise in Athletic Horses by Means of Raman Spectroscopy.Animals : an open access journal from MDPI · 2023Article
- Sugars, Sweet Taste Receptors, and Brain Responses.Nutrients · 2017Review
- Relationships between gastric emptying, postprandial glycemia, and incretin hormones.Diabetes care · 2013Review
- Peripheral neural targets in obesity.British journal of pharmacology · 2012Review
- Effects of GLP-1 and incretin-based therapies on gastrointestinal motor function.Experimental diabetes research · 2011Review
- Sensing via intestinal sweet taste pathways.Frontiers in neuroscience · 2011Article
- Upper gastrointestinal function and glycemic control in diabetes mellitus.World journal of gastroenterology · 2006Review
- Incretins and the development of type 2 diabetes.Current diabetes reports · 2006Review
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Glucagon-like peptide 1 does not comfortably fulfil the criterion of a gut derived factor responsible for an enhanced meal related insulin response; it appears logical to add the definition of a "physiological incretin hormone".
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.